Literature DB >> 403796

Pulmonary venoocclusive disease: case report and review of the literature.

G D Shackelford, E J Sacks, J D Mullins, W H McAlister.   

Abstract

A fatal case of pulmonary venoocclusive disease in a 4-year-old boy is reported, with emphasis on the radiologic features of this condition. The disease is characterized by fibrous intimal obliteration of the lumina of small pulmonary veins and venules leading to severe secondary pulmonary arterial hypertension. The clinical picture is usually indistinguishable from that of other forms of pulmonary arterial hypertnesion, but radiologic features of postcapillary pulmonary hypertension, in conjunction with a normal venoocclusive disease. The diagnosis is definitively established by lung biopsy.

Entities:  

Mesh:

Year:  1977        PMID: 403796     DOI: 10.2214/ajr.128.4.643

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Severe pulmonary artery hypertension.

Authors:  A Roglan; A Artigas; J Solé
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

2.  Pulmonary veno-occlusive disease: antemortem diagnosis from roentgenographic and hemodynamic findings.

Authors:  V S Rambihar; E L Fallen; J A Cairns
Journal:  Can Med Assoc J       Date:  1979-06-23       Impact factor: 8.262

3.  Pulmonary venous occlusion and death in pulmonary arterial hypertension: survival analyses using radiographic surrogates.

Authors:  Yasuko Takeda; Yutaka Takeda; Koji Yamamoto; Shigehiro Tomimoto; Tomomitsu Tani; Hitomi Narita; Nobuyuki Ohte; Genjiro Kimura
Journal:  BMC Pulm Med       Date:  2011-10-06       Impact factor: 3.317

4.  Haemosiderin-laden sputum macrophages for diagnosis in pulmonary veno-occlusive disease.

Authors:  Heidi Lederer; Bettina Muggli; Rudolf Speich; Ula Treder; Hans Stricker; Jeroen Goede; Silvia Ulrich; Simon F Stämpfli; Alexander Breitenstein
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.